<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30459813</article-id>
<article-id pub-id-type="pmc">6232662</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2018.00539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pilot Safety Evaluation of a Novel Strain of <italic>Bacteroides ovatus</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Huizi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Zhiming</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Qingsong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Jianxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/599533/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhai</surname>
<given-names>Qixiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/513253/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>State Key Laboratory of Food Science and Technology, Jiangnan University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Food Science and Technology, Jiangnan University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Wuxi People’s Hospital Affiliated to Nanjing Medical University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>National Engineering Research Center for Functional Food, Jiangnan University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>International Joint Research Laboratory for Probiotics, Jiangnan University</institution>, <addr-line>Wuxi</addr-line>, <country>China</country></aff>
<aff id="aff6"><sup>6</sup><institution>Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tao Huang, Shanghai Institutes for Biological Sciences (CAS), China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jiachao Zhang, Hainan University, China; Yun Li, University of Pennsylvania, United States</p>
</fn>
<corresp id="c001">*Correspondence: Qixiao Zhai, <email>zhaiqixiao@sina.com</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Bioinformatics and Computational Biology, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>539</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Tan, Yu, Wang, Zhang, Zhao, Zhang, Zhai and Chen.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Tan, Yu, Wang, Zhang, Zhao, Zhang, Zhai and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><italic>Bacteroides ovatus</italic> ELH-B2 is considered as a potential next-generation probiotic due to its preventive effects on lipopolysaccharides-associated inflammation and intestinal microbiota disorders in mice. To study safety issues associated with <italic>B. ovatus</italic> ELH-B2, we conducted comprehensive and systematic experiments, including <italic>in vitro</italic> genetic assessments of potential virulence and antimicrobial resistance genes, and an <italic>in vivo</italic> acute toxicity study of both immunocompetent and immunosuppressed mice via cyclophosphamide treatment. The results indicated that this novel strain is non-toxigenic, fragilysin is not expressed, and most of potential virulence genes are correlated with cellular structures such as capsular polysaccharide and polysaccharide utilizations. The antibiotic resistance features are unlikely be transferred to other intestinal microorganisms as no plasmids nor related genomic islands were identified. Side effects were not observed in mice. <italic>B. ovatus</italic> ELH-B2 also alleviated the damages caused by cyclophosphamide injection.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Bacteroides ovatus</italic>
</kwd>
<kwd>safety evaluation</kwd>
<kwd>antibiotic resistance</kwd>
<kwd>virulence genes</kwd>
<kwd>next-generation probiotics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source>
<award-id rid="cn001">31470161</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Natural Science Foundation of Jiangsu Province<named-content content-type="fundref-id">10.13039/501100004608</named-content></funding-source>
<award-id rid="cn002">BK20160175</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="54"></ref-count>
<page-count count="12"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Probiotics, prebiotics, and antibiotics are the most relevant therapies for disorders induced by disturbed microbiota. Traditional probiotics mainly refer to <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic>, which are normally obtained from traditional fermented foods and are widely accepted as food ingredients or supplements for daily intake, with a prediction of global turnover value of US$46.55 billion by 2020 (<xref ref-type="bibr" rid="B38">O’Toole et al., 2017</xref>).</p>
<p>Beneficial strains other than the traditional probiotics have been discovered due to the developments in bacterial culture methodologies and sequencing techniques and have started to be authorized as ingredients in food, particularly from <italic>Bacteroides</italic> which is one of the most abundant genera in the human intestine. For example, <italic>Bacteroides xylanisolvens</italic> DSM23964, which promotes the maturation of natural antibodies against cancers in humans, has recently been permitted to be added to pasteurized milk products under Novel Food Regulation No. 258/97 by the European Commission (<xref ref-type="bibr" rid="B4">Brodmann et al., 2017</xref>); <italic>B. uniformis</italic> CECT7771 can improve overweight-induced disorders by reducing the levels of cholesterol and triglyceride (<xref ref-type="bibr" rid="B6">Cano et al., 2012</xref>), with no obvious damages identified <italic>in vivo</italic> (<xref ref-type="bibr" rid="B14">Fernandez-Murga and Sanz, 2016</xref>).</p>
<p><italic>B. ovatus</italic> is another dominant species identified as next-generation probiotics either in its original form with sufficient tumor-specific Thomsen–Friedenreich antigen expressed for cancer prevention (<xref ref-type="bibr" rid="B46">Ulsemer et al., 2013</xref>), or genetically modified with genes encoding human keratinocyte growth factors (<xref ref-type="bibr" rid="B20">Hamady et al., 2010</xref>) or transforming growth factors (<xref ref-type="bibr" rid="B21">Hamady et al., 2011</xref>) to facilitate therapies for bowel diseases. However, the beneficial functions of <italic>Bacteroides</italic> are strain-dependent, such as the polysaccharides A (PSA)-producing <italic>B. fragilis</italic> is capable of relieving <italic>Helicobacter hepaticus</italic> associated inflammation and autism spectrum disorders (<xref ref-type="bibr" rid="B33">Mazmanian et al., 2008</xref>; <xref ref-type="bibr" rid="B24">Hsiao et al., 2013</xref>), but the fragilysin (bft)-carrying <italic>B. fragilis</italic> directly contributes to severe colitis (<xref ref-type="bibr" rid="B54">Yim et al., 2013</xref>), emphasizing the necessities for safety evaluations of each potentially beneficial strain.</p>
<p>Previously, we established an efficient method for purifying low-abundant <italic>Bacteroides</italic> species from the human intestine (<xref ref-type="bibr" rid="B45">Tan et al., 2018</xref>), and discovered that one of the isolates, <italic>B. ovatus</italic> ELH-B2 displaying promising potentials of modulating lipopolysaccharides (LPS)-induced disorders in cytokine secretions and intestinal microbiota through restoring the balance of regulatory T cells (Tregs) and T helper 17 (Th-17) cells (data unpublished). In this study, a pilot safety assessment of this novel strain was carried out, including explorations of its hemolytic and motile characteristics, antibiotic resistance, genetic virulence factors, and underlying side effects in both normal and immunosuppressed mice.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Bacterial Strains and Culture Conditions</title>
<p><italic>Bacteroides ovatus</italic> ELH-B2 was recovered from the in-house preservations at Culture Collections of Food Microbiology (CCFM), Jiangnan University (Wuxi, China). <italic>B. ovatus</italic> JCM5824 was purchased from RIKEN BioResource Center, Japan. <italic>Salmonella enterica</italic> CMCC50335 and <italic>Escherichia coli</italic> CMCC44102 were acquired from the National Center for Medical Culture Collections, China.</p>
<p><italic>Salmonella enterica</italic> and <italic>E. coli</italic> were anaerobically cultured in brain heart infusion (BHI, Hopebio, China) at 37°C. The <italic>B. ovatus</italic> strains were cultured in BHI supplemented with hemin (Sangon Biotech, China) and vitamin K1 (BHIS) at 37°C in anaerobic chamber for further analysis of bacterial characterizations. The bacteria solutions for <italic>in vivo</italic> tests were prepared with cells at early stationary phase after centrifugation at 6000 rpm for 15 min and re-suspension in phosphate buffer saline supplemented with 20% glycerol, and maintained at -80°C. Cell viability after freezing and thawing was evaluated via colony-forming unit (cfu) enumeration on BHIS agar before use.</p>
</sec>
<sec>
<title>Bacterial Characterizations</title>
<p><italic>Bacteroides ovatus</italic> type strain JCM5824 was used as control for the bacterial characterization assessments of ELH-B2. Hemolytic capabilities were examined by dropping 5 μl of overnight culture on Brucella agar (Hopebio, China) supplemented with hemin, vitamin K1 and 5% sheep blood (Nanjing SenBeiJia Biological Technology Co., Ltd., China) (<xref ref-type="bibr" rid="B39">Robertson et al., 2006</xref>). Motility was tested via standard motility agar assays using BHIS broth supplemented with 0.5% (w/v) agar (soft agar) (<xref ref-type="bibr" rid="B9">Cousin et al., 2015</xref>), inoculated with 5 μl of overnight culture and incubated anaerobically for 48 h. <italic>S. enterica</italic> CMCC50335 was adopted as the positive control and <italic>E. coli</italic> CMCC44102 as the negative control. All of the experiments were carried out in three biological replicates.</p>
</sec>
<sec>
<title>Genome Sequencing and Screening of Potential Virulence Factors</title>
<p>The genomic DNA was extracted from <italic>B. ovatus</italic> ELH-B2 culture at early stationary phase and sequenced with Illumina Hiseq system by Majorbio (China). Library of average insert size of 410 bp was generated with low-quality reads filtered. The genome was assembled using SOAPdenovo v2.04<sup><xref ref-type="fn" rid="fn01">1</xref></sup> (<xref ref-type="bibr" rid="B30">Li et al., 2008</xref>; <xref ref-type="bibr" rid="B31">Li et al., 2010</xref>) followed by gap closure and base correction using GapCloser v1.12. A <italic>K</italic>-mer value of 23 was determined according to the accuracy evaluation. Gene annotation was performed by blastp (BLAST 2.2.28+) against Nr, Swiss-prot, string and GO databases. In order to show the relationships between <italic>B. ovatus</italic> ELH-B2 and other <italic>B. ovatus</italic> isolates, whose genome sequences were available from the NCBI database<sup><xref ref-type="fn" rid="fn02">2</xref></sup>, a neighbor-joining phylogenetic tree (<xref ref-type="bibr" rid="B3">Bottacini et al., 2014</xref>) was established by phyML<sup><xref ref-type="fn" rid="fn03">3</xref></sup> (<xref ref-type="bibr" rid="B17">Guindon et al., 2009</xref>) after alignment of homologous genes identified by graph theory-based Markov clustering algorithm using mafft<sup><xref ref-type="fn" rid="fn04">4</xref></sup> (<xref ref-type="bibr" rid="B26">Katoh and Standley, 2013</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Phylogenetic tree based on the complete genome sequences of <italic>Bacteroides ovatus</italic> ELH-B2 and other <italic>B. ovatus</italic> strains.</p>
</caption>
<graphic xlink:href="fgene-09-00539-g001"></graphic>
</fig>
<p>Putative antibiotic resistance genes and virulence genes were identified in the genome of <italic>B. ovatus</italic> ELH-B2 by using a Protein-translated nucleotide Basic Local Search Tool (tblastn) according to the Comprehensive Antibiotic Resistance Database (CARD<sup><xref ref-type="fn" rid="fn05">5</xref></sup> (<xref ref-type="bibr" rid="B34">McArthur et al., 2013</xref>) and the Virulence Factor Database (VFDB<sup><xref ref-type="fn" rid="fn06">6</xref></sup>) (<xref ref-type="bibr" rid="B7">Chen et al., 2012</xref>) respectively. Positive results were accepted with at least 30% identity and 70% coverage, and e-value less than 0.01 (<xref ref-type="bibr" rid="B42">Salvetti et al., 2016</xref>). Genetic islands were also predicted using IslandPath-DIMOB and Islander (<xref ref-type="bibr" rid="B32">Lu and Leong, 2016</xref>) for identifying putative virulence factors and possibilities of transportation of antibiotics resistance genes between bacteria. Moreover, <italic>Bacteroides</italic>-specific virulence factors including bft, ompW, upaY, upaZ, wcfR, wcfS, cfiA, cepA, and cfxA, of which the amino acid sequences were acquired from the NCBI database (Table <xref ref-type="table" rid="T1">1B</xref>), were screened in <italic>B. ovatus</italic> ELH-B2 using tblastn based on BioEdit v7.2.5 with e-value less than 1e-5. The genome sequence of <italic>B. ovatus</italic> JCM5824 (GenBank accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NZ_CP012938">NZ_CP012938</ext-link>) was analyzed for comparison.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>(A)</bold> Identification of potential virulence factors in the genome of <italic>Bacteroides ovatus</italic> ELH-B2 according to VFDB database; <bold>(B)</bold> prediction of putative genomic islands of over 30 kb in the genome of <italic>B. ovatus</italic> ELH-B2; <bold>(C)</bold> comparison of <italic>Bacteroides</italic>-specific virulence genes in <italic>B. ovatus</italic> ELH-B2 and JCM5824.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>VFDB_ID</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Name</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Description</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Original source</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Identity</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Coverage</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold><italic>e-</italic>value</bold>
</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000077</td>
<td align="left" colspan="1" rowspan="1" valign="top">clpP</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATP-dependent Clp protease proteolytic subunit</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Listeria monocytogenes</italic> EGD-e</td>
<td align="left" colspan="1" rowspan="1" valign="top">54%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-67</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000165</td>
<td align="left" colspan="1" rowspan="1" valign="top">pchF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pyochelin synthetase PchF</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Pseudomonas aeruginosa</italic> PAO1</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">88%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000321</td>
<td align="left" colspan="1" rowspan="1" valign="top">rfbD</td>
<td align="left" colspan="1" rowspan="1" valign="top">GDP-<sc>D</sc>-mannose dehydratase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Helicobacter pylori</italic> 26695</td>
<td align="left" colspan="1" rowspan="1" valign="top">59%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-136</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000366</td>
<td align="left" colspan="1" rowspan="1" valign="top">ybtQ</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inner membrane ABC-transporter YbtQ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia pestis</italic> CO92</td>
<td align="left" colspan="1" rowspan="1" valign="top">56%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000574</td>
<td align="left" colspan="1" rowspan="1" valign="top">mgtB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mg2<sup>+</sup> transport protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Salmonella enterica</italic> subsp. <italic>enterica</italic> serovar Typhimurium str. LT2</td>
<td align="left" colspan="1" rowspan="1" valign="top">55%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00E+00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG000696</td>
<td align="left" colspan="1" rowspan="1" valign="top">bexA</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATP-dependent polysaccharide export protein BexA</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Haemophilus influenzae</italic> str. 1007</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001266</td>
<td align="left" colspan="1" rowspan="1" valign="top">pchI</td>
<td align="left" colspan="1" rowspan="1" valign="top">ABC transporter ATP-binding protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Pseudomonas aeruginosa</italic> PAO1</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001269</td>
<td align="left" colspan="1" rowspan="1" valign="top">cyaB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyclolysin secretion ATP-binding protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bordetella pertussis</italic> Tohama I</td>
<td align="left" colspan="1" rowspan="1" valign="top">59%</td>
<td align="left" colspan="1" rowspan="1" valign="top">75%</td>
<td align="left" colspan="1" rowspan="1" valign="top">8.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001301</td>
<td align="left" colspan="1" rowspan="1" valign="top">cap8E</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capsular polysaccharide synthesis enzyme Cap8E</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Staphylococcus aureus</italic> subsp. <italic>aureus</italic> MW2</td>
<td align="left" colspan="1" rowspan="1" valign="top">63%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-137</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001303</td>
<td align="left" colspan="1" rowspan="1" valign="top">cap8G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capsular polysaccharide synthesis enzyme Cap8G</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Staphylococcus aureus</italic> subsp. <italic>aureus</italic> MW2</td>
<td align="left" colspan="1" rowspan="1" valign="top">57%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-140</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001341</td>
<td align="left" colspan="1" rowspan="1" valign="top">cpsJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycosyl transferase CpsJ(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus agalactiae</italic> 2603V/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">58%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001342</td>
<td align="left" colspan="1" rowspan="1" valign="top">cpsO</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycosyl transferase CpsO(V)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus agalactiae</italic> 2603V/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">56%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001374</td>
<td align="left" colspan="1" rowspan="1" valign="top">cps4J</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capsular polysaccharide biosynthesis protein Cps4J</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus pneumoniae</italic> TIGR4</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">85%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-160</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001375</td>
<td align="left" colspan="1" rowspan="1" valign="top">cps4K</td>
<td align="left" colspan="1" rowspan="1" valign="top">Capsular polysaccharide biosynthesis protein Cps4K</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus pneumoniae</italic> TIGR4</td>
<td align="left" colspan="1" rowspan="1" valign="top">61%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-169</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001376</td>
<td align="left" colspan="1" rowspan="1" valign="top">cps4L</td>
<td align="left" colspan="1" rowspan="1" valign="top">UDP-<italic>N</italic>-acetylglucosamine 2-epimerase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus pneumoniae</italic> TIGR4</td>
<td align="left" colspan="1" rowspan="1" valign="top">79%</td>
<td align="left" colspan="1" rowspan="1" valign="top">90%</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00E+00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001855</td>
<td align="left" colspan="1" rowspan="1" valign="top">htpB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hsp60, 60K heat shock protein HtpB</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Legionella pneumophila</italic> subsp. <italic>pneumophila</italic> str. Philadelphia 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">59%</td>
<td align="left" colspan="1" rowspan="1" valign="top">77%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-168</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001937</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cj1136</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glucosyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter jejuni</italic> NCTC11168</td>
<td align="left" colspan="1" rowspan="1" valign="top">48%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001939</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cj1138</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycosyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter jejuni</italic> NCTC11168</td>
<td align="left" colspan="1" rowspan="1" valign="top">47%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001940</td>
<td align="left" colspan="1" rowspan="1" valign="top">wlaN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Beta-1,3 galactosyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter jejuni</italic> NCTC11168</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG001968</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cj1440c</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sugar transferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter jejuni</italic> NCTC11168</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002181</td>
<td align="left" colspan="1" rowspan="1" valign="top">cpsJ</td>
<td align="left" colspan="1" rowspan="1" valign="top">ABC transporter, ATP-binding protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus faecalis</italic> V583</td>
<td align="left" colspan="1" rowspan="1" valign="top">58%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002187</td>
<td align="left" colspan="1" rowspan="1" valign="top">cpsD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycosyl transferase, group 2 family protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterococcus faecalis</italic> V583</td>
<td align="left" colspan="1" rowspan="1" valign="top">36%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002225</td>
<td align="left" colspan="1" rowspan="1" valign="top">gmd</td>
<td align="left" colspan="1" rowspan="1" valign="top">GDP-mannose 4,6-dehydratase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Brucella melitensis</italic> bv. 1 str. 16M</td>
<td align="left" colspan="1" rowspan="1" valign="top">69%</td>
<td align="left" colspan="1" rowspan="1" valign="top">81%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-156</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002365</td>
<td align="left" colspan="1" rowspan="1" valign="top">gmd</td>
<td align="left" colspan="1" rowspan="1" valign="top">GDP-mannose 4,6-dehydratase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia enterocolitica</italic> 8081</td>
<td align="left" colspan="1" rowspan="1" valign="top">64%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-151</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002368</td>
<td align="left" colspan="1" rowspan="1" valign="top">wbcG</td>
<td align="left" colspan="1" rowspan="1" valign="top">Putative glycosyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia enterocolitica</italic> 8081</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002376</td>
<td align="left" colspan="1" rowspan="1" valign="top">ddhB</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDP-glucose 4,6-dehydratase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia enterocolitica</italic> 8081</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-113</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002377</td>
<td align="left" colspan="1" rowspan="1" valign="top">ddhA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glucose-1-phosphate cytidylyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia enterocolitica</italic> 8081</td>
<td align="left" colspan="1" rowspan="1" valign="top">58%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-94</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002440</td>
<td align="left" colspan="1" rowspan="1" valign="top">bprB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Two-component response regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Burkholderia pseudomallei</italic> K96243</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002480</td>
<td align="left" colspan="1" rowspan="1" valign="top">tssH-5/clpV</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clp-type ATPase chaperone protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Burkholderia pseudomallei</italic> K96243</td>
<td align="left" colspan="1" rowspan="1" valign="top">56%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-83</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG002563</td>
<td align="left" colspan="1" rowspan="1" valign="top">wzt2</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATP-binding ABC transporter capsular polysaccharide export protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Burkholderia pseudomallei</italic> K96243</td>
<td align="left" colspan="1" rowspan="1" valign="top">51%</td>
<td align="left" colspan="1" rowspan="1" valign="top">80%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG005773</td>
<td align="left" colspan="1" rowspan="1" valign="top">cylZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">3R-hydroxymyristoyl ACP dehydratase CylZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus agalactiae</italic> 2603V/R</td>
<td align="left" colspan="1" rowspan="1" valign="top">52%</td>
<td align="left" colspan="1" rowspan="1" valign="top">86%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG011414</td>
<td align="left" colspan="1" rowspan="1" valign="top">kdsA</td>
<td align="left" colspan="1" rowspan="1" valign="top">2-dehydro-3-deoxyphosphooctonate aldolase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Brucella melitensis</italic> bv. 1 str. 16M</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-65</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG011430</td>
<td align="left" colspan="1" rowspan="1" valign="top">acpXL</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acyl carrier protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Brucella melitensis</italic> bv. 1 str. 16M</td>
<td align="left" colspan="1" rowspan="1" valign="top">64%</td>
<td align="left" colspan="1" rowspan="1" valign="top">80%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-24</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG012509</td>
<td align="left" colspan="1" rowspan="1" valign="top">iroC</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATP binding cassette transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> CFT073</td>
<td align="left" colspan="1" rowspan="1" valign="top">45%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG013354</td>
<td align="left" colspan="1" rowspan="1" valign="top">kfiC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lipopolysaccharide biosynthesis protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Haemophilus influenzae</italic> Rd KW20</td>
<td align="left" colspan="1" rowspan="1" valign="top">47%</td>
<td align="left" colspan="1" rowspan="1" valign="top">83%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG013368</td>
<td align="left" colspan="1" rowspan="1" valign="top">rffG</td>
<td align="left" colspan="1" rowspan="1" valign="top">dTDP-glucose 46-dehydratase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Haemophilus influenzae</italic> Rd KW20</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG013471</td>
<td align="left" colspan="1" rowspan="1" valign="top">lgtA</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>N</italic>-acetylglucosamine glycosyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Haemophilus influenzae</italic> Rd KW20</td>
<td align="left" colspan="1" rowspan="1" valign="top">48%</td>
<td align="left" colspan="1" rowspan="1" valign="top">80%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG037028</td>
<td align="left" colspan="1" rowspan="1" valign="top">katA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Catalase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Neisseria meningitidis</italic> MC58</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">82%</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00E+00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG037386</td>
<td align="left" colspan="1" rowspan="1" valign="top">bauE</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ferric siderophore ABC transporter, ATP-binding protein BauE</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Acinetobacter baumannii</italic> ACICU</td>
<td align="left" colspan="1" rowspan="1" valign="top">42%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">8.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG038722</td>
<td align="left" colspan="1" rowspan="1" valign="top">AHA_1389</td>
<td align="left" colspan="1" rowspan="1" valign="top">CobQ/CobB/MinD/ParA family protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Aeromonas hydrophila</italic> ATCC7966</td>
<td align="left" colspan="1" rowspan="1" valign="top">51%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG038918</td>
<td align="left" colspan="1" rowspan="1" valign="top">rtxE</td>
<td align="left" colspan="1" rowspan="1" valign="top">RTX toxin transporter, ATPase protein</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Aeromonas hydrophila</italic> ATCC7966</td>
<td align="left" colspan="1" rowspan="1" valign="top">63%</td>
<td align="left" colspan="1" rowspan="1" valign="top">77%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG043373</td>
<td align="left" colspan="1" rowspan="1" valign="top">cheA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histidine kinase CheA</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Helicobacter pylori</italic> 26695</td>
<td align="left" colspan="1" rowspan="1" valign="top">39%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG043394</td>
<td align="left" colspan="1" rowspan="1" valign="top">cheA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chemotaxis histidine kinase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter jejuni</italic> NCTC11168</td>
<td align="left" colspan="1" rowspan="1" valign="top">34%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">VFG045340</td>
<td align="left" colspan="1" rowspan="1" valign="top">ricA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rab2 interacting conserved protein A</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Brucella melitensis</italic> bv. 1 str. 16M</td>
<td align="left" colspan="1" rowspan="1" valign="top">43%</td>
<td align="left" colspan="1" rowspan="1" valign="top">75%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-07</td>
</tr>
</tbody>
</table>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="4" rowspan="1" valign="top">(B)<hr/></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Island no.</th>
<th align="left" colspan="1" rowspan="1" valign="top">Genes in island</th>
<th align="left" colspan="1" rowspan="1" valign="top">Size (kb)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Potential functional genes within island</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1</td>
<td align="left" colspan="1" rowspan="1" valign="top">g0188–g0233</td>
<td align="left" colspan="1" rowspan="1" valign="top">37.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zeta-toxin (g0214); antitoxin (g0215)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2</td>
<td align="left" colspan="1" rowspan="1" valign="top">g0842–g0866</td>
<td align="left" colspan="1" rowspan="1" valign="top">35.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Arabinan endo-1,5-alpha-<sc>L</sc>-arabinosidase (g0844); SusC/RagA family TonB-linked outer membrane protein (g0846); glycosyl hydrolase (g0842, g0851, g0854)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3</td>
<td align="left" colspan="1" rowspan="1" valign="top">g0978–g1164</td>
<td align="left" colspan="1" rowspan="1" valign="top">170</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thiamine biosynthesis protein ApbE (g0984); tonB-linked outer membrane, SusC/RagA family protein (g1005, g1062, g1092); CepA family class A extended-spectrum beta-lactamase (g1025); xylulokinase (g1107)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">g1544–g1594</td>
<td align="left" colspan="1" rowspan="1" valign="top">34.9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Type IV secretory pathway TrbF components (g1575)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">g1605–g1720</td>
<td align="left" colspan="1" rowspan="1" valign="top">105.8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycosyl transferase 2 family protein (g1616, g1619); two-component sensor histidine kinase (g1646);, TonB-dependent receptor (g1709)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">g1837–g1864</td>
<td align="left" colspan="1" rowspan="1" valign="top">32.2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Membrane protein (g1855); iron ABC transporter ATP-binding protein (g1864)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">g2583–g2631</td>
<td align="left" colspan="1" rowspan="1" valign="top">33.3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Redox-active disulfide protein (g2584); thioredoxin (g2585); conjugal transfer protein TraG (g2600, g2610), TraA (g2605), TraH (g2611), TraJ (g2613), TraK (g2614), TraM (g2616), TraN (g2617)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8</td>
<td align="left" colspan="1" rowspan="1" valign="top">g2866–g2999</td>
<td align="left" colspan="1" rowspan="1" valign="top">91.7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phage Mu F like family protein (g2947); phage tail tape measure protein, TP901 family, core region (g2955); toxin-antitoxin system, antitoxin component, MerR family (g2998)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">g3114–g3160</td>
<td align="left" colspan="1" rowspan="1" valign="top">41.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>N</italic>-acetylmuramoyl-<sc>L</sc>-alanine amidase (g3133)</td>
</tr>
</tbody>
</table>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="6" rowspan="1" valign="top">(C)<hr/></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Potential virulence factors</th>
<th align="left" colspan="1" rowspan="1" valign="top">GenBank accession number</th>
<th align="center" colspan="1" rowspan="1" valign="top">Size (aa)</th>
<th align="left" colspan="1" rowspan="1" valign="top">% Similarity in <italic>B. ovatus</italic> ELH-B2</th>
<th align="left" colspan="1" rowspan="1" valign="top">% Similarity in <italic>B. ovatus</italic> JCM5824</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">bft</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAF72837.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">63</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B19">Gutacker et al., 2000</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ompW</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAL09385.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">947</td>
<td align="left" colspan="1" rowspan="1" valign="top">95% (904/947)</td>
<td align="left" colspan="1" rowspan="1" valign="top">95% (901/947)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B51">Wei et al., 2001</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">upaY</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAK68912.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">172</td>
<td align="left" colspan="1" rowspan="1" valign="top">29% (48/163)</td>
<td align="left" colspan="1" rowspan="1" valign="top">30% (48/160)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B10">Coyne et al., 2001</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">upaZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAK68913.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">157</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">wcfR</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAK68921.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">407</td>
<td align="left" colspan="1" rowspan="1" valign="top">20% (88/407)</td>
<td align="left" colspan="1" rowspan="1" valign="top">25% (101/395)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">wcfS</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAK68922.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">198</td>
<td align="left" colspan="1" rowspan="1" valign="top">48% (68/141)</td>
<td align="left" colspan="1" rowspan="1" valign="top">48% (68/141)</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">cfiA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAK71520</td>
<td align="center" colspan="1" rowspan="1" valign="top">111</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top">No hit</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B18">Gutacker et al., 2002</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">cfxA</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAP78899.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">306</td>
<td align="left" colspan="1" rowspan="1" valign="top">40% (111/273)</td>
<td align="left" colspan="1" rowspan="1" valign="top">40% (110/273)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B15">Garcia et al., 2008</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">cepA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAA21538.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">300</td>
<td align="left" colspan="1" rowspan="1" valign="top">77% (233/299)</td>
<td align="left" colspan="1" rowspan="1" valign="top">77% (233/299)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B40">Rogers et al., 1994</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Minimum Inhibitory Concentration (MIC) of Different Antibiotics</title>
<p>Fourteen antibiotics, corresponding to ampicillin, cefoxitin, ceftriaxone, penicillin G, and vancomycin which suppress cell wall synthesis; chloromycetin, clindamycin, erythromycin, kanamycin, streptomycin, and tetracycline which restrain protein synthesis; ciprofloxacin and metronidazole which inhibit nucleic acid synthesis; and polymyxin B which suppresses cytoplasmic functions, were applied to determine the antibiotic resistance profiles of <italic>B. ovatus</italic> ELH-B2, with the type strain of JCM5824 as comparison. <italic>B. ovatus</italic> overnight culture (100 μl) at a concentration of 10<sup>7</sup> cfu/ml was treated with serially diluted antibiotics from 0.125 to 1024 μg/ml in sterile 96-well plates. The optical density at 600 nm was checked with a microplate reader (Multiskan GO, Thermo Scientific, United States) after anaerobic cultivation at 37°C for 48 h. The MIC of each antibiotic was determined by the lowest concentration that inhibited 90% of the growth of the tested <italic>B. ovatus</italic> strains (<xref ref-type="bibr" rid="B11">D’Aimmo et al., 2007</xref>). All of the experiments were carried out in three biological replicates.</p>
</sec>
<sec>
<title>Animals</title>
<p>Male C57 mice (7 weeks old, spf grade) were purchased from Shanghai Laboratory Animal Center (China) and raised within the IVC rodent caging system at Jiangnan University. The mice were maintained under a 12-h light/dark cycle with temperature and humidity strictly controlled. Treatment was initiated after acclimatization for at least 1 week. The entire experiment was approved by the Animal Ethics Committee of Jiangnan University (JN. No. 20180415c0450730[61]), and protocols for the care and use of experimental animals were based on the European Community guidelines (Directive 2010/63/EU).</p>
</sec>
<sec>
<title>Acute Toxicity to Immunocompetent and Immunosuppressed Mice</title>
<p>Both immunocompetent and immunosuppressed mice were involved in this acute toxicity assessment of <italic>B. ovatus</italic> ELH-B2. The immunocompetent mice, comprising control group (CTRL, 6 mice) and <italic>B. ovatus</italic> ELH-B2 group (BO, 6 mice), were given 150 μl of PBS/glycerol solution or 10<sup>9</sup> cfu <italic>B. ovatus</italic> ELH-B2 solution by gavage, respectively, every 24 h for 5 days. The other 12 mice were immunosuppressed by intraperitoneal injection with 250 mg/kg of cyclophosphamide (CTX, Sigma-Aldrich, United States), and were allocated to CTX group or CTX + BO group 3 days after followed by daily oral administration of 150 μl of PBS/glycerol solution or 10<sup>9</sup> cfu <italic>B. ovatus</italic> ELH-B2 solution, respectively, for 5 days (<xref ref-type="bibr" rid="B22">Hirsh et al., 2004</xref>; <xref ref-type="bibr" rid="B41">Salva et al., 2014</xref>).</p>
<p>The behavior and body weight of each mouse were monitored and recorded throughout the experiments. All of the mice were anesthetized with sodium pentobarbital and sacrificed by cervical dislocation. Liver, spleen and colon tissues and blood samples were collected immediately after sacrifice for further investigations.</p>
</sec>
<sec>
<title>Assays of Hematological and Liver Parameters</title>
<p>Hematological parameters were assessed using automatic hematology analyzer (BC-5000, Mindray, China) and associated buffers with fresh blood samples. The liver parameters were examined using automatic biochemical analyzer (BS-480) and corresponding kits (Mindray, China) with serum obtained by centrifuging the blood samples at 2500 rpm for 10 min. The serum standard (Shanghai Zhicheng Biological Technology Co. Ltd., China) was used for quality control.</p>
</sec>
<sec>
<title>Cytokine Concentrations in Serum</title>
<p>The secretions of tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) were determined using mouse Elisa kits purchased from Nanjing SenBeiJia Biological Technology Co., Ltd. (China) with serum samples, according to the manufacturer’s instructions.</p>
</sec>
<sec>
<title>Histological Analysis</title>
<p>Liver, spleen and colon tissues were preserved in 4% paraformaldehyde solution and then embedded in paraffin. The histological analysis was conducted using Hematoxylin-Eosin (H&amp;E) staining as published (<xref ref-type="bibr" rid="B2">Al-Hashmi et al., 2011</xref>). Images were recorded using Pannoramic digital slide scanner (Pannoramic MIDI II, 3DHISTECH Ltd., Hungary).</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Significant differences between groups were determined by unpaired Student’s <italic>t</italic>-test using Graphpad Prism v5.0 (Graph Pad Software Inc., United States), with <italic>p</italic>-values of less than 0.05. All of the data were presented as mean ± SD.</p>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Microbiological Properties</title>
<p><italic>Bacteroides ovatus</italic> ELH-B2 grew well at 37°C on the Brucella agar supplemented with laked sheep blood under strict anaerobic conditions. The colonies were round, semi-opaque with smooth edges, and the bacteria were Gram-negative and rod shaped, which matches the description of <italic>B. ovatus</italic> in <italic>Bergey’s Manual</italic> (<xref ref-type="bibr" rid="B28">Krieg et al., 2001</xref>). Similar to the type strain <italic>B. ovatus</italic> JCM5824, ELH-B2 was confirmed to be non-motile, but slightly hemolytic.</p>
</sec>
<sec>
<title>Genetic Characteristics and Identification of Potential Virulence Factors</title>
<p>The size of the complete genome of <italic>B. ovatus</italic> ELH-B2 is 1 206 654 732 base pair, including 102 scaffolds and 5909 genes. The GC concent is 41.98%. The genomic information indicates the most similar strain to <italic>B. ovatus</italic> ELH-B2 is <italic>B. ovatus</italic> CL03T12C18 (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<p>According to the blast against VFDB database, 44 virulence factor homologs were identified in <italic>B. ovatus</italic> ELH-B2 (Table <xref ref-type="table" rid="T1">1A</xref>), most of which correlate with cellular structures like capsular polysaccharide and polysaccharide utilizations such as glycosyltransferase, and yet have been discovered as the pathogenesis of <italic>B. ovatus</italic>. And there are nine predicted genomic islands of over 30 kb (Table <xref ref-type="table" rid="T1">1B</xref>), six of which are metabolism-related. Toxin-antitoxin system-associated genes were discovered two of the potential genomic islands, and one of the components in the Type IV secretion system (T4SS) were also identified.</p>
<p>As for the <italic>Bacteroides</italic>-specific virulence factors (Table <xref ref-type="table" rid="T1">1C</xref>), Similar to <italic>B. ovatus</italic> JCM5824, <italic>B. ovatus</italic> ELH-B2 does not contain the diarrhea-associated <italic>B. fragilis</italic> enterotoxin bft. The coding gene of TonB-linked outer membrane protein (ompW), which has been implicated in inflammatory bowel disease (IBD) (<xref ref-type="bibr" rid="B51">Wei et al., 2001</xref>), were identified in both <italic>B. ovatus</italic> strains with high similarity. No hits or only low matches were identified in ELH-B2 for the highly conserved open reading frames, upaY and upaZ, and another two genes critical for synthesizing capsular PSA, wcfR and wcfS. And among the three β-lactamase-associated genes, only cepA was found in the two genomic sequences with high similarity.</p>
</sec>
<sec>
<title>Minimum Inhibitory Concentrations of Antibiotics</title>
<p>As shown in Table <xref ref-type="table" rid="T2">2A</xref>, the potential antibiotic resistance genes indicated the possibilities of <italic>B. ovatus</italic> ELH-B2 to survive under the treatment of tetracycline, kanamycin, macrolide antibiotics like erythromycin, cationic antibiotics like polymyxin B, and glycopeptide like vancomycin. Accordingly, the MIC experiments verified that <italic>B. ovatus</italic> ELH-B2 was resistant to these antibiotics except tetracycline (Table <xref ref-type="table" rid="T2">2B</xref>). It was also clinically susceptible to penicillin, cefoxitin, chloromycetin, and metronidazole with MICs of no more than 32 μg/ml (<xref ref-type="bibr" rid="B11">D’Aimmo et al., 2007</xref>). The lowest MIC of ELH-B2 was 4 μg/ml during treatment with metronidazole. Clindamycin and erythromycin were able to inhibit the growth of <italic>B. ovatus</italic> JCM5824 rather than ELH-B2.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p><bold>(A)</bold> Predicted genes associated with antibiotic resistance in the genome of <italic>B. ovatus</italic> ELH-B2; <bold>(B)</bold> minimum inhibitory concentrations for antibiotics against <italic>B. ovatus</italic> ELH-B2 and <italic>B. ovatus</italic> JCM5824 (μg/ml).</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CARD_ID</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Name</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Description</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Original source</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Identity</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Coverage</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold><italic>e-</italic>value</bold>
</td>
</tr>
<tr>
<td align="left" colspan="7" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000191</td>
<td align="left" colspan="1" rowspan="1" valign="top">tetQ</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bacteroides fragilis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">96%</td>
<td align="left" colspan="1" rowspan="1" valign="top">98%</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00E + 00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000197</td>
<td align="left" colspan="1" rowspan="1" valign="top">tet36</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides coprosuis</italic> DSM 18011</td>
<td align="left" colspan="1" rowspan="1" valign="top">60%</td>
<td align="left" colspan="1" rowspan="1" valign="top">79%</td>
<td align="left" colspan="1" rowspan="1" valign="top">0.00E + 00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000206</td>
<td align="left" colspan="1" rowspan="1" valign="top">emrK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Major facilitator superfamily (MFS) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Escherichia coli</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">41%</td>
<td align="left" colspan="1" rowspan="1" valign="top">73%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000250</td>
<td align="left" colspan="1" rowspan="1" valign="top">ErmC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Erythromycin resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Staphylococcus epidermidis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-72</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000375</td>
<td align="left" colspan="1" rowspan="1" valign="top">ErmB</td>
<td align="left" colspan="1" rowspan="1" valign="top">Erythromycin resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Enterococcus faecium</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">98%</td>
<td align="left" colspan="1" rowspan="1" valign="top">99%</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.00E-158</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000499</td>
<td align="left" colspan="1" rowspan="1" valign="top">acrE</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> str. K-12 substr. MG1655</td>
<td align="left" colspan="1" rowspan="1" valign="top">46%</td>
<td align="left" colspan="1" rowspan="1" valign="top">73%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000768</td>
<td align="left" colspan="1" rowspan="1" valign="top">abeS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Small multidrug resistance (SMR) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Acinetobacter baumannii</italic> AB307-0294</td>
<td align="left" colspan="1" rowspan="1" valign="top">64%</td>
<td align="left" colspan="1" rowspan="1" valign="top">81%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000816</td>
<td align="left" colspan="1" rowspan="1" valign="top">mtrA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Mycobacterium tuberculosis</italic> H37Rv</td>
<td align="left" colspan="1" rowspan="1" valign="top">40%</td>
<td align="left" colspan="1" rowspan="1" valign="top">75%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-07</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3000828</td>
<td align="left" colspan="1" rowspan="1" valign="top">baeR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> str. K-12 substr. W3110</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002522</td>
<td align="left" colspan="1" rowspan="1" valign="top">novA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Type III ABC transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptomyces niveus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002626</td>
<td align="left" colspan="1" rowspan="1" valign="top">ANT(6)-Ia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aminoglycoside nucleotidyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Exiguobacterium</italic> sp. S3-2</td>
<td align="left" colspan="1" rowspan="1" valign="top">62%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-114</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002627</td>
<td align="left" colspan="1" rowspan="1" valign="top">aadK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aminoglycoside nucleotidyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacillus subtilis</italic> subsp. <italic>subtilis</italic> str. 168</td>
<td align="left" colspan="1" rowspan="1" valign="top">58%</td>
<td align="left" colspan="1" rowspan="1" valign="top">76%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-102</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002628</td>
<td align="left" colspan="1" rowspan="1" valign="top">aad(6)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aminoglycoside nucleotidyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptococcus oralis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">64%</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-107</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002629</td>
<td align="left" colspan="1" rowspan="1" valign="top">ANT(6)-Ib</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aminoglycoside nucleotidyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Campylobacter fetus</italic> subsp. Fetus</td>
<td align="left" colspan="1" rowspan="1" valign="top">73%</td>
<td align="left" colspan="1" rowspan="1" valign="top">87%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-133</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002817</td>
<td align="left" colspan="1" rowspan="1" valign="top">carA</td>
<td align="left" colspan="1" rowspan="1" valign="top">ABC transporter involved in macrolide resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptomyces thermotolerans</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">46%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002825</td>
<td align="left" colspan="1" rowspan="1" valign="top">ErmY</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Staphylococcus aureus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">52%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-70</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002827</td>
<td align="left" colspan="1" rowspan="1" valign="top">tlrC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptomyces fradiae</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">47%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002830</td>
<td align="left" colspan="1" rowspan="1" valign="top">vgaALC</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efflux protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Staphylococcus haemolyticus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">56%</td>
<td align="left" colspan="1" rowspan="1" valign="top">75%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002845</td>
<td align="left" colspan="1" rowspan="1" valign="top">vatH</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acetyl transferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Enterococcus faecium</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">45%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002871</td>
<td align="left" colspan="1" rowspan="1" valign="top">tet37</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Uncultured bacterium</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">65%</td>
<td align="left" colspan="1" rowspan="1" valign="top">79%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3002925</td>
<td align="left" colspan="1" rowspan="1" valign="top">vanRF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycopeptide resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Paenibacillus popilliae</italic> ATCC14706</td>
<td align="left" colspan="1" rowspan="1" valign="top">44%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003036</td>
<td align="left" colspan="1" rowspan="1" valign="top">oleB</td>
<td align="left" colspan="1" rowspan="1" valign="top">ABC transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptomyces antibioticus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">46%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003048</td>
<td align="left" colspan="1" rowspan="1" valign="top">rosA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efflux pump for resistance to cationic antimicrobial peptides such as polymyxin B</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Yersinia enterocolitica</italic> (type O:8)</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-96</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003109</td>
<td align="left" colspan="1" rowspan="1" valign="top">msrE</td>
<td align="left" colspan="1" rowspan="1" valign="top">ABC-efflux pump for resistance to erythromycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Escherichia coli</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">65%</td>
<td align="left" colspan="1" rowspan="1" valign="top">81%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003548</td>
<td align="left" colspan="1" rowspan="1" valign="top">mdtN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multidrug resistance efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> str. K-12 substr. W3110</td>
<td align="left" colspan="1" rowspan="1" valign="top">43%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">5.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003559</td>
<td align="left" colspan="1" rowspan="1" valign="top">cepA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Beta-lactamase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bacteroides fragilis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">78%</td>
<td align="left" colspan="1" rowspan="1" valign="top">89%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-157</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003577</td>
<td align="left" colspan="1" rowspan="1" valign="top">ugd</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance to cationic antimicrobial peptides</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> str. K-12 substr. MG1655</td>
<td align="left" colspan="1" rowspan="1" valign="top">58%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7.00E-156</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003728</td>
<td align="left" colspan="1" rowspan="1" valign="top">vanRI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycopeptide resistance gene</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Desulfitobacterium hafniense</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">42%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003744</td>
<td align="left" colspan="1" rowspan="1" valign="top">vatF</td>
<td align="left" colspan="1" rowspan="1" valign="top">Streptogramin A acetyl transferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Yersinia enterocolitica</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">44%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-08</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003836</td>
<td align="left" colspan="1" rowspan="1" valign="top">qacH</td>
<td align="left" colspan="1" rowspan="1" valign="top">Small multidrug resistance (SMR) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Vibrio cholerae</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-29</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003841</td>
<td align="left" colspan="1" rowspan="1" valign="top">kdpE</td>
<td align="left" colspan="1" rowspan="1" valign="top">Adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia coli</italic> str. K-12 substr. MG1655</td>
<td align="left" colspan="1" rowspan="1" valign="top">43%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003922</td>
<td align="left" colspan="1" rowspan="1" valign="top">oqxA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RND efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Escherichia coli</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">56%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003971</td>
<td align="left" colspan="1" rowspan="1" valign="top">erm(44)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance to lincosamide and macrolide antibiotics</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Staphylococcus saprophyticus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">49%</td>
<td align="left" colspan="1" rowspan="1" valign="top">73%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-67</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003986</td>
<td align="left" colspan="1" rowspan="1" valign="top">TaeA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Paenibacillus</italic> sp. LC231</td>
<td align="left" colspan="1" rowspan="1" valign="top">43%</td>
<td align="left" colspan="1" rowspan="1" valign="top">74%</td>
<td align="left" colspan="1" rowspan="1" valign="top">3.00E-05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3003987</td>
<td align="left" colspan="1" rowspan="1" valign="top">VatI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acetyltransferase for resistance to streptogramin A antibiotics</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Paenibacillus</italic> sp. LC231</td>
<td align="left" colspan="1" rowspan="1" valign="top">43%</td>
<td align="left" colspan="1" rowspan="1" valign="top">72%</td>
<td align="left" colspan="1" rowspan="1" valign="top">6.00E-04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3004038</td>
<td align="left" colspan="1" rowspan="1" valign="top">emrE</td>
<td align="left" colspan="1" rowspan="1" valign="top">Multidrug transporter for resistance to kanamycin</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Pseudomonas aeruginosa</italic> PAO1</td>
<td align="left" colspan="1" rowspan="1" valign="top">50%</td>
<td align="left" colspan="1" rowspan="1" valign="top">73%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3004039</td>
<td align="left" colspan="1" rowspan="1" valign="top">emrE</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efflux pump for resistance to erythromycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Escherichia coli</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">4.00E-30</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3004042</td>
<td align="left" colspan="1" rowspan="1" valign="top">acrA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance-nodulation-cell division (RND) antibiotic efflux pump</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Enterobacter cloacae</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">45%</td>
<td align="left" colspan="1" rowspan="1" valign="top">70%</td>
<td align="left" colspan="1" rowspan="1" valign="top">1.00E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARO:3004451</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chloramphenicol acetyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chloramphenicol acetyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Agrobacterium tumefaciens</italic> str. C58</td>
<td align="left" colspan="1" rowspan="1" valign="top">53%</td>
<td align="left" colspan="1" rowspan="1" valign="top">71%</td>
<td align="left" colspan="1" rowspan="1" valign="top">2.00E-10</td>
</tr>
</tbody>
</table>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="3" rowspan="1" valign="top">(B)<hr/></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Antibiotics</th>
<th align="left" colspan="1" rowspan="1" valign="top"><italic>B. ovatus</italic> ELH-B2</th>
<th align="left" colspan="1" rowspan="1" valign="top"><italic>B. ovatus</italic> JCM5824</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ampicillin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 64</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 128</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Penicillin G</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 32</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vancomycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 64</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 64</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cefoxitin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 16</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ceftriaxone</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 256</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 128</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Clindamycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 1024</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 0.25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chloromycetin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 16</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Erythromycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 1024</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kanamycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC &gt; 1024</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC &gt; 1024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Streptomycin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC &gt; 1024</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC &gt; 1024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tetracycline</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC &lt; 0.125</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Metronidazole</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ciprofloxacin</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 64</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 16</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Polymyxin B</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 512</td>
<td align="left" colspan="1" rowspan="1" valign="top">MIC ≤ 128</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title><italic>In vivo</italic> Toxicity of <italic>B. ovatus</italic> ELH-B2</title>
<p>All of the animals were alive and healthy at the end of the experiment, and no abnormal behaviors were witnessed. Although the immunosuppressed mice displayed significantly less body weights, <italic>B. ovatus</italic> ELH-B2 treatment did not induce obvious alterations in the body mass of healthy or cyclophosphamide-injected mice (Figure <xref ref-type="fig" rid="F2">2A</xref>). Concerning the organ index, which refers to the ratio of organ weight to body weight, ELH-B2 had very little effect on liver indexes in immunocompetent mice, and did not enhance the enlarged spleen indexes of the drug-injected mice (Figure <xref ref-type="fig" rid="F2">2B</xref>). Colon length was also not notably influenced by the administration of ELH-B2.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Impact of <italic>B. ovatus</italic> ELH-B2 on <bold>(A)</bold> the body weight and <bold>(B)</bold> the organ indexes of immunocompetent and immunosuppressed mice. The organ indexes of the liver and spleen are expressed as the ratio of the corresponding weight of the organ and body, while the colon index is expressed as the colon length of each animal. Data are displayed as mean ± SD, “##” indicates statistically significant differences between the CTX + BO group and the CTRL group (<italic>p</italic> &lt; 0.01).</p>
</caption>
<graphic xlink:href="fgene-09-00539-g002"></graphic>
</fig>
<p><italic>B. ovatus</italic> ELH-B2 intervention did not show significant alterations in the hematological (Table <xref ref-type="table" rid="T3">3A</xref>) or liver parameters (Table <xref ref-type="table" rid="T3">3B</xref>) of normal mice. After CTX injection, the percentages of lymphocytes (<italic>p</italic> &lt; 0.01), hemoglobin concentration (<italic>p</italic> &lt; 0.001), hematocrit value (<italic>p</italic> &lt; 0.01) and platelets enumeration (<italic>p</italic> &lt; 0.05) were markedly dropped, and the percentage of neutrophils were dramatically increased (<italic>p</italic> &lt; 0.01). However, during the treatment with ELH-B2, the hematocrit value of the immunosuppressed mice was recovered (<italic>p</italic> &lt; 0.01) and corpuscular volume was also significantly increased (<italic>p</italic> &lt; 0.01). As for the liver parameters, CTX induced notable upregulation of alanine aminotransferase (<italic>p</italic> &lt; 0.05), and concentration of alkaline phosphatase was dropped to normal level due to the administration of ELH-B2 in CTX-treated mice (<italic>p</italic> &lt; 0.01).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Profiles of <bold>(A)</bold> hematological values and <bold>(B)</bold> liver parameters in immunocompetent and immunosuppressed mice after 5-day treatments with <italic>B. ovatus</italic> ELH-B2.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CTRL</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>BO</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CTX</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>CTX + BO</bold>
</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">WBC (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.47 ± 0.38</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.76 ± 0.64</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.19 ± 0.43</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.21 ± 0.92</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neu (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.73 ± 0.23</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.40 ± 0.20</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.92 ± 0.38#</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.01 ± 0.65</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lym (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.56 ± 0.49</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.31 ± 0.48</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.15 ± 0.17##</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.10 ± 0.31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mon (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.05 ± 0.02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03 ± 0.02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.08 ± 0.04</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.09 ± 0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Eos (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.02 ± 0.02</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.01 ± 0.01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03 ± 0.01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.04 ± 0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bas (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.02 ± 0.01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.01 ± 0.01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.02 ± 0.01</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03 ± 0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neu (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">14.76 ± 5.61</td>
<td align="center" colspan="1" rowspan="1" valign="top">13.90 ± 4.10</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.27 ± 10.93##</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.44 ± 4.86</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lym (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">83.16 ± 5.67</td>
<td align="center" colspan="1" rowspan="1" valign="top">84.00 ± 4.58</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.17 ± 12.04##</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.95 ± 4.41</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mon (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.30 ± 0.60</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.10 ± 0.58</td>
<td align="center" colspan="1" rowspan="1" valign="top">3.17 ± 1.23#</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.93 ± 0.90</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Eos (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.36 ± 0.19</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.57 ± 0.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.33 ± 0.40##</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.90 ± 0.37</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bas (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.42 ± 0.13</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.43 ± 0.14</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.07 ± 0.66</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.35 ± 0.23</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RBC (10ˆ12/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.44 ± 0.23</td>
<td align="center" colspan="1" rowspan="1" valign="top">10.07 ± 0.46</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.35 ± 0.20</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.88 ± 0.32</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HGB (g/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">171.40 ± 3.14</td>
<td align="center" colspan="1" rowspan="1" valign="top">168.00 ± 3.92</td>
<td align="center" colspan="1" rowspan="1" valign="top">141.33 ± 3.30###</td>
<td align="center" colspan="1" rowspan="1" valign="top">147.50 ± 6.60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HCT (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">49.78 ± 0.93</td>
<td align="center" colspan="1" rowspan="1" valign="top">48.65 ± 0.70</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.90 ± 0.73###</td>
<td align="center" colspan="1" rowspan="1" valign="top">44.98 ± 2.12**</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MCV (fL)</td>
<td align="center" colspan="1" rowspan="1" valign="top">47.72 ± 0.28</td>
<td align="center" colspan="1" rowspan="1" valign="top">48.08 ± 0.38</td>
<td align="center" colspan="1" rowspan="1" valign="top">47.80 ± 0.29</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.17 ± 0.65**</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MCH (pg)</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.98 ± 0.17</td>
<td align="center" colspan="1" rowspan="1" valign="top">17.27 ± 0.26</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.93 ± 0.25</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.43 ± 0.27</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MCHC (g/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">356.20 ± 4.71</td>
<td align="center" colspan="1" rowspan="1" valign="top">358.67 ± 5.02</td>
<td align="center" colspan="1" rowspan="1" valign="top">354.00 ± 4.55</td>
<td align="center" colspan="1" rowspan="1" valign="top">356.50 ± 3.59</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RDW-CV (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.56 ± 0.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.83 ± 0.38</td>
<td align="center" colspan="1" rowspan="1" valign="top">12.63 ± 0.09</td>
<td align="center" colspan="1" rowspan="1" valign="top">13.07 ± 0.59</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RDW-SD (fL)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26.88 ± 0.53</td>
<td align="center" colspan="1" rowspan="1" valign="top">27.45 ± 0.73</td>
<td align="center" colspan="1" rowspan="1" valign="top">29.07 ± 0.74</td>
<td align="center" colspan="1" rowspan="1" valign="top">29.77 ± 1.06</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PLT (10ˆ9/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1227.60 ± 171.16</td>
<td align="center" colspan="1" rowspan="1" valign="top">1059.25 ± 49.44</td>
<td align="center" colspan="1" rowspan="1" valign="top">907.33 ± 109.00#</td>
<td align="center" colspan="1" rowspan="1" valign="top">984.50 ± 160.82</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MPV (fL)</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.50 ± 0.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.38 ± 0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.00 ± 0.22</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.93 ± 0.22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PDW (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.54 ± 0.12</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.43 ± 0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.77 ± 0.25</td>
<td align="center" colspan="1" rowspan="1" valign="top">15.98 ± 0.17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PCT (%)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.68 ± 0.10</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.54 ± 0.05</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.55 ± 0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.58 ± 0.09</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib><italic>WBC, white blood cells; Neu, neutrophils; Lym, lymphocytes; Mon, monocytes; Eos, eosinophils; Bas, basophils; RBC, red blood cells; HGB, hemoglobin concentration; HCT, hematocrit value; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW, red cell distribution width; CV, coefficient of variation; SD, standard deviation; PLT, platelet; MPV, mean platelet volume; PDW, platelet distribution width; PCT, thrombocytocrit</italic>. <italic>Data are displayed as mean ± SD, “<sup>∗∗</sup>” indicates statistically significant differences between the CTX + BO group and the CTX group (p &lt; 0.01); “#”, “##,” and “###” indicate statistically significant differences between the CTX + BO group and the CTRL group (p &lt; 0.05, p &lt; 0.01 and p &lt; 0.001, respectively)</italic>.</attrib>
</table-wrap-foot>
</table-wrap>
<table-wrap id="d35e3035" position="float">
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="5" rowspan="1" valign="top">(B)<hr/></th>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="center" colspan="1" rowspan="1" valign="top">CTRL</th>
<th align="center" colspan="1" rowspan="1" valign="top">BO</th>
<th align="center" colspan="1" rowspan="1" valign="top">CTX</th>
<th align="center" colspan="1" rowspan="1" valign="top">CTX + BO</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Glu (mmol/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.40 ± 0.49</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.59 ± 0.56</td>
<td align="center" colspan="1" rowspan="1" valign="top">7.07 ± 0.96</td>
<td align="center" colspan="1" rowspan="1" valign="top">6.76 ± 0.40</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TC (mmol/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.87 ± 0.23</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.90 ± 0.28</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.78 ± 0.28</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.77 ± 0.17</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TG (mmol/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.51 ± 0.31</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.58 ± 0.11</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.56 ± 0.45</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.36 ± 0.46</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALT (U/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">16.30 ± 1.41</td>
<td align="center" colspan="1" rowspan="1" valign="top">17.85 ± 1.57</td>
<td align="center" colspan="1" rowspan="1" valign="top">24.00 ± 3.82#</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.08 ± 1.21</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AST (U/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">175.06 ± 1.42</td>
<td align="center" colspan="1" rowspan="1" valign="top">178.44 ± 13.43</td>
<td align="center" colspan="1" rowspan="1" valign="top">172.50 ± 36.94</td>
<td align="center" colspan="1" rowspan="1" valign="top">180.48 ± 32.45</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TBIL (μmol /L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.94 ± 0.64</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.96 ± 0.34</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.39 ± 0.43</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.27 ± 0.35</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALP (U/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.25 ± 3.90</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.40 ± 2.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">8.25 ± 3.27</td>
<td align="center" colspan="1" rowspan="1" valign="top">5.00 ± 1.41**</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TP (g/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.80 ± 3.17</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.70 ± 4.99</td>
<td align="center" colspan="1" rowspan="1" valign="top">44.10 ± 2.36</td>
<td align="center" colspan="1" rowspan="1" valign="top">44.50 ± 1.47</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ALB (g/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.44 ± 2.62</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.05 ± 3.57</td>
<td align="center" colspan="1" rowspan="1" valign="top">27.80 ± 1.81</td>
<td align="center" colspan="1" rowspan="1" valign="top">27.60 ± 1.60</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CK (U/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2072.58 ± 203.93</td>
<td align="center" colspan="1" rowspan="1" valign="top">2262.52 ± 284.58</td>
<td align="center" colspan="1" rowspan="1" valign="top">2431.00 ± 974.13</td>
<td align="center" colspan="1" rowspan="1" valign="top">2256.23 ± 676.64</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LDH (U/L)</td>
<td align="center" colspan="1" rowspan="1" valign="top">423.83 ± 228.77</td>
<td align="center" colspan="1" rowspan="1" valign="top">465.80 ± 69.24</td>
<td align="center" colspan="1" rowspan="1" valign="top">511.00 ± 63.94</td>
<td align="center" colspan="1" rowspan="1" valign="top">516.30 ± 62.95</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>Glu, glucose; TC, total cholesterol; TG, triglyceride; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; ALP, alkaline phosphatase; TP, total protein; ALB, albumin; CK, creatine kinase; LDH, lactic dehydrogenase.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
<p>No obvious modifications in cytokine productions were observed after the treatment of <italic>B. ovatus</italic> ELH-B2 in both healthy and immunosuppressed mice (Figure <xref ref-type="fig" rid="F3">3</xref>). Treatment with <italic>B. ovatus</italic> ELH-B2 did not lead to any histopathological damage in the liver, spleen or colon of the healthy mice (Figure <xref ref-type="fig" rid="F4">4</xref>). However, the CTX-treated mice suffered from hypertrophy of spleen, the histological structure of which was severely damaged with obvious fibrosis and hemorrhage. The red and white pulps could not be well-defined and splenocytes were irregularly aligned (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Impact of <italic>B. ovatus</italic> ELH-B2 on the cytokine productions of immunocompetent and immunosuppressed mice. Data are displayed as mean ± SD.</p>
</caption>
<graphic xlink:href="fgene-09-00539-g003"></graphic>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Impact of <italic>B. ovatus</italic> ELH-B2 on the tissue histology of immunocompetent and immunosuppressed mice.</p>
</caption>
<graphic xlink:href="fgene-09-00539-g004"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>Evidences of indigenous and genetically modified intestinal commensals which obtain underlying efficacy in modulating immune and metabolic disorders, extend the range of probiotics, and are termed “next-generation probiotics” or “live biotherapeutic products.” The United States Food and Drug Administration (FDA) provide a definition for live biotherapeutic products as “a biological product that contains live organisms, such as bacteria, and is applicable to the prevention, treatment or cure of a disease or condition of human beings, but is not a vaccine,” which is also suitable for next-generation probiotics (<xref ref-type="bibr" rid="B38">O’Toole et al., 2017</xref>). In the meantime, the FDA drafted guidance that next-generation probiotics should be authorized as food ingredients when first entering the market. However, specific guidelines for applications of these promising microorganisms are yet to be developed. Therefore, a safety evaluation of <italic>B. ovatus</italic> ELH-B2 was carried out according to the regulations of the FAO/WHO for development of probiotics, in which explained the importance of complete bacterial characterizations such as original source, culture history, phenotype and genotype, antibiotic resistance, and manufacturing methods and three-step clinical trials, including safety assessment and functional characterization; double blind, randomized, placebo-controlled human studies; and efficiency comparisons with standard treatments, and published toxicity analyses of <italic>Lactobacillus</italic> spp. (<xref ref-type="bibr" rid="B53">Yakabe et al., 2009</xref>; <xref ref-type="bibr" rid="B25">Jia et al., 2011</xref>), <italic>B. xylanisolvens</italic> DSM23964 (<xref ref-type="bibr" rid="B47">Ulsemer et al., 2012a</xref>,<xref ref-type="bibr" rid="B48">b</xref>), <italic>B. uniformis</italic> CECT7771 (<xref ref-type="bibr" rid="B14">Fernandez-Murga and Sanz, 2016</xref>), and <italic>B. fragilis</italic> ZY312 (<xref ref-type="bibr" rid="B49">Wang et al., 2017</xref>), along with previous results which revealed that ELH-B2 had little effect on the production of secretory immunoglobulin A (sIgA) and chemokine (C-X-C motif) ligand 2 (CXCL2) or the balance of Treg and Th-17 cells, and even upregulated the diversity of intestinal microbiota (unpublished data).</p>
<p>Morphological analysis showed that <italic>B. ovatus</italic> ELH-B2 cells were non-motile, which excluded the pathogenic factor of flagella for inducing inflammation via activating the NF-κB pathway through Toll-like receptor 5 and secreting IL-8 (<xref ref-type="bibr" rid="B37">Neville et al., 2012</xref>), and facilitating nutrient acquisition, niche colonization (<xref ref-type="bibr" rid="B29">Lane et al., 2007</xref>; <xref ref-type="bibr" rid="B37">Neville et al., 2012</xref>), and biofilm formation (<xref ref-type="bibr" rid="B23">Houry et al., 2010</xref>). The translucent circles around ELH-B2 colonies on blood agar plates indicated the possible existence of hemolysin, which is a pore-forming toxin with cytolytic functions on various types of cells, such as keratinocytes, epithelial cells, and lymphocytes (<xref ref-type="bibr" rid="B27">Kennedy et al., 2010</xref>; <xref ref-type="bibr" rid="B52">Wilke and Wardenburg, 2010</xref>).</p>
<p>The virulence factors discovered via the Virulence Factor Database include genes facilitating protein secretion, carbohydrates degradation and maintaining cellular structures. These elements could be probiosis-related and contribute to bacterial adhesion and colonization, rather than pathogenicity (<xref ref-type="bibr" rid="B50">Wassenaar et al., 2015</xref>). The majority of the predict islands were discovered to be metabolism-related. Although TrbF of T4SS were identified, the rest preserved genes were absent. Thus <italic>B. ovatus</italic> ELH-B2 are not capable of producing the entire secretion systems for any possibilities of transfering virulence protein and antibiotic resistance genes (<xref ref-type="bibr" rid="B1">Aguilar et al., 2010</xref>). Moreover, toxin-antitoxin system are widely existed in natural bacteria strains for better adaptive ability to the environment resulted from evolution (<xref ref-type="bibr" rid="B5">Buts et al., 2005</xref>), the virulence characteristics of which requires further analysis.</p>
<p><italic>Bacteroides</italic> species are, to some extent, considered to be opportunistic pathogens as some of them are carriers of virulence factors, such as the enterotoxigenic <italic>B. fragilis</italic> with bft (<xref ref-type="bibr" rid="B43">Sears, 2009</xref>) and <italic>B. caccae</italic> with ompW (<xref ref-type="bibr" rid="B51">Wei et al., 2001</xref>). The metalloprotease bft was not identified in ELH-B2, but ompW was found to be 95% identical. The protein encoded by ompW in <italic>B. caccae</italic> was discovered by pANCA monoclonal antibody in IBD patients and is closely associated with a pathogenic factor of <italic>Porphyromonas gingivalis</italic> that contributes to tissue damage. However, this TonB-linked structure of ompW is also conserved in the starch-utilization system of <italic>Bacteroides</italic> species that helps to break down resistant carbohydrates in the host. Hence, the underlying role of the ompW-like structure in ELH-B2 requires further investigation. Meanwhile, the blast results of the four genes essential for constructing PSA indicated the absence of the capsular polysaccharide, which suggests that ELH-B2 does not possess the PSA-associated anti-inflammatory character (<xref ref-type="bibr" rid="B33">Mazmanian et al., 2008</xref>), but also avoids the consequently potential abscess formation (<xref ref-type="bibr" rid="B8">Cohen-Poradosu et al., 2011</xref>).</p>
<p>Overall, the putative antibiotic resistance gene list based on the Comprehensive Antibiotic Resistance Database are almost in correspondence to the antibiotic resistance profiles of <italic>B. ovatus</italic> ELH-B2 acquired from MIC experiments. <italic>B. ovatus</italic> ELH-B2 was found to be less susceptible to antibiotics compared with the type strain. The three genes encoding β-lactamase, corresponding to cfxA for class A cephalosporinase, cfiA for class B metallo-β-lactamase and cepA for endogenous cephalosporinase (<xref ref-type="bibr" rid="B15">Garcia et al., 2008</xref>), were not or were only partially aligned in the genome of ELH-B2, which was consistent with the result that the novel strain was clinically resistant to penicillin G and cefoxitin. It is notable that neither plasmid nor antibiotic resistance-related genomic islands were found in the genome, indicating low chances of transferring the characteristics of antibiotic resistance to other intestinal commensals.</p>
<p>In general, the results demonstrated that <italic>B. ovatus</italic> ELH-B2 showed no oral pathogenicity in healthy animals with a daily dose of 10<sup>9</sup> cfu live cells, which is the appropriate concentration for commercial application that guarantees both the viability and integrity of bacterial cells after freeze-drying and restoration procedures (<xref ref-type="bibr" rid="B35">Miyamoto-Shinohara et al., 2000</xref>). Based on a mean body weight of 20 g for the mice, 3.5 × 10<sup>12</sup> cfu of ELH-B2 cells are predicted to be safe for a 70 kg healthy human adult.</p>
<p>In the meantime, confidence in authorizing treatments for industrial and clinical applications would be enhanced once no side effects of the bacteria have been confirmed in immunodeficient animals (<xref ref-type="bibr" rid="B13">FAO/WHO, 2002</xref>). In this study, immunosuppressed condition was established via CTX injection, which is one of the most commonly used as a chemotherapeutic treatment for cancers and as an immunosuppressive agent before myeloablative therapies (<xref ref-type="bibr" rid="B12">Ehrke, 2003</xref>). Accordingly, the cytotoxicity was reflected in liver which is the first target organ engaging all toxic drugs (<xref ref-type="bibr" rid="B44">Singh et al., 2018</xref>), and spleen which is responsible for the immune status by controlling the proliferation of T cells, B cells and lymphocytes (<xref ref-type="bibr" rid="B16">Gong et al., 2015</xref>). CTX treatment led to distinctly upregulated liver parameter of alanine aminotransferase, injuries in spleen and disturbed hematological values.</p>
<p>Nevertheless, <italic>B. ovatus</italic> ELH-B2 did not accelerate the toxicities of CTX. Besides, the restoration of alkaline phosphatase revealed a recovery effect on the liver and pancreatic functions. Alkaline phosphatase contributes to the dephosphorylation of LPS from the gut by circulation (<xref ref-type="bibr" rid="B36">Moreira et al., 2012</xref>), and thereby the downregulation of which emphasized the capability of the <italic>Bacteroides</italic> to help reduce the threats of endotoxemia in the mice. This result corresponds to the previous characterization study of this novel strain. A reduction in the secretion of TNF-α was observed with <italic>B. ovatus</italic> ELH-B2 treatment, demonstrating its potential anti-inflammatory function, although in a non-significant way.</p>
<p>In summary, <italic>B. ovatus</italic> ELH-B2, a novel strain which was confirmed to be capable of attenuating LPS-induced inflammation <italic>in vivo</italic>, did not raise severe safety issues in either immunocompetent or immunosuppressed mice, and even partially relieved the side effects associated with the chemotherapeutic drug. Further assessments of viable doses and extreme conditions, such as intraperitoneal injection of bacteria, should be considered (<xref ref-type="bibr" rid="B48">Ulsemer et al., 2012b</xref>).</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>HT and ZY carried out the experiment and drafted the manuscript. CW and QinZ participated in the analysis of the data. JZ and HZ provided the essential reagents and materials. QixZ conceived of the study and managed the project design. WC helped to revise the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by the National Natural Science Foundation of China (No. 31871773 and 31470161, and Key Program No. 31530056), the Natural Science Foundation of Jiangsu Province (BK20160175 and BK20141098), the National First-Class Discipline Program of Food Science and Technology (JUFSTR20180102), and the Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.</p>
</fn>
</fn-group>
<fn-group>
<fn id="fn01">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://soap.genomics.org.cn/">http://soap.genomics.org.cn/</ext-link>
</p>
</fn>
<fn id="fn02">
<label>2</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>
</p>
</fn>
<fn id="fn03">
<label>3</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.atgc-montpellier.fr/phyml/">http://www.atgc-montpellier.fr/phyml/</ext-link>
</p>
</fn>
<fn id="fn04">
<label>4</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://mafft.cbrc.jp/alignment/software/">https://mafft.cbrc.jp/alignment/software/</ext-link>
</p>
</fn>
<fn id="fn05">
<label>5</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://arpcard.mcmaster.ca/">http://arpcard.mcmaster.ca/</ext-link>
</p>
</fn>
<fn id="fn06">
<label>6</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://www.mgc.ac.cn/VFs/main.htm">http://www.mgc.ac.cn/VFs/main.htm</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar</surname><given-names>J.</given-names></name><name><surname>Zupan</surname><given-names>J.</given-names></name><name><surname>Cameron</surname><given-names>T. A.</given-names></name><name><surname>Zambryski</surname><given-names>P. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Agrobacterium type IV secretion system and its substrates form helical arrays around the circumference of virulence-induced cells.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>2</volume>
<fpage>3758</fpage>–<lpage>3763</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914940107</pub-id>
<pub-id pub-id-type="pmid">20133577</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hashmi</surname><given-names>S.</given-names></name><name><surname>Hassan</surname><given-names>Z.</given-names></name><name><surname>Sadeghi</surname><given-names>B.</given-names></name><name><surname>Rozell</surname><given-names>B.</given-names></name><name><surname>Hassan</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen.</article-title>
<source/><italic>Int. J. Clin. Exp. Pathol.</italic>
<volume>4</volume>
<fpage>596</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="pmid">21904635</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottacini</surname><given-names>F.</given-names></name><name><surname>Motherway</surname><given-names>M. O.</given-names></name><name><surname>Kuczynski</surname><given-names>J.</given-names></name><name><surname>O’Connell</surname><given-names>K. J.</given-names></name><name><surname>Serafini</surname><given-names>F.</given-names></name><name><surname>Duranti</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Comparative genomics of the <italic>Bifidobacterium breve</italic> taxon.</article-title>
<source/><italic>BMC Genomics</italic>
<volume>15</volume>:<issue>170</issue>. <pub-id pub-id-type="doi">10.1186/1471-2164-15-170</pub-id>
<pub-id pub-id-type="pmid">24581150</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodmann</surname><given-names>T.</given-names></name><name><surname>Endo</surname><given-names>A.</given-names></name><name><surname>Gueimonde</surname><given-names>M.</given-names></name><name><surname>Vinderola</surname><given-names>G.</given-names></name><name><surname>Kneifel</surname><given-names>W.</given-names></name><name><surname>de Vos</surname><given-names>W. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Safety of novel microbes for human consumption: practical examples of assessment in the European Union.</article-title>
<source/><italic>Front. Microbiol.</italic>
<volume>8</volume>:<issue>15</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01725</pub-id>
<pub-id pub-id-type="pmid">28955311</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buts</surname><given-names>L.</given-names></name><name><surname>Lah</surname><given-names>J.</given-names></name><name><surname>Dao-Thi</surname><given-names>M. H.</given-names></name><name><surname>Wyns</surname><given-names>L.</given-names></name><name><surname>Loris</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Toxin-antitoxin modules as bacterial metabolic stress managers.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>12</volume>
<fpage>672</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2005.10.004</pub-id>
<pub-id pub-id-type="pmid">16257530</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cano</surname><given-names>P. G.</given-names></name><name><surname>Santacruz</surname><given-names>A.</given-names></name><name><surname>Moya</surname><given-names>A.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Bacteroides uniformis</italic> CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e41079</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0041079</pub-id>
<pub-id pub-id-type="pmid">22844426</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L. H.</given-names></name><name><surname>Xiong</surname><given-names>Z. H.</given-names></name><name><surname>Sun</surname><given-names>L. L.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>Q.</given-names></name></person-group> (<year>2012</year>). <article-title>VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>40</volume>
<fpage>D641</fpage>–<lpage>D645</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr989</pub-id>
<pub-id pub-id-type="pmid">22067448</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen-Poradosu</surname><given-names>R.</given-names></name><name><surname>McLoughlin</surname><given-names>R. M.</given-names></name><name><surname>Lee</surname><given-names>J. C.</given-names></name><name><surname>Kasper</surname><given-names>D. L.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Bacteroides fragilis</italic>-stimulated interleukin-10 contains expanding disease.</article-title>
<source/><italic>J. Infect. Dis.</italic>
<volume>204</volume>
<fpage>363</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jir277</pub-id>
<pub-id pub-id-type="pmid">21742834</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousin</surname><given-names>F. J.</given-names></name><name><surname>Lynch</surname><given-names>S. M.</given-names></name><name><surname>Harris</surname><given-names>H. M. B.</given-names></name><name><surname>McCann</surname><given-names>A.</given-names></name><name><surname>Lynch</surname><given-names>D. B.</given-names></name><name><surname>Neville</surname><given-names>B. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Detection and genomic characterization of motility in <italic>Lactobacillus curvatus</italic>: confirmation of motility in a species outside the <italic>Lactobacillus salivarius</italic> clade.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>81</volume>
<fpage>1297</fpage>–<lpage>1308</lpage>. <pub-id pub-id-type="doi">10.1128/aem.03594-14</pub-id>
<pub-id pub-id-type="pmid">25501479</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>M. J.</given-names></name><name><surname>Tzianabos</surname><given-names>A. O.</given-names></name><name><surname>Mallory</surname><given-names>B. C.</given-names></name><name><surname>Carey</surname><given-names>V. J.</given-names></name><name><surname>Kasper</surname><given-names>D. L.</given-names></name><name><surname>Comstock</surname><given-names>L. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Polysaccharide biosynthesis locus required for virulence of <italic>Bacteroides fragilis</italic>.</article-title>
<source/><italic>Infect. Immun.</italic>
<volume>69</volume>
<fpage>4342</fpage>–<lpage>4350</lpage>. <pub-id pub-id-type="doi">10.1128/iai.69.7.4342-4350.2001</pub-id>
<pub-id pub-id-type="pmid">11401972</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Aimmo</surname><given-names>M. R.</given-names></name><name><surname>Modesto</surname><given-names>M.</given-names></name><name><surname>Biavati</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.</article-title>
<source/><italic>Int. J. Food Microbiol.</italic>
<volume>115</volume>
<fpage>35</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.10.003</pub-id>
<pub-id pub-id-type="pmid">17198739</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrke</surname><given-names>M. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Immunomodulation in cancer therapeutics.</article-title>
<source/><italic>Int. Immunopharmacol.</italic>
<volume>3</volume>
<fpage>1105</fpage>–<lpage>1119</lpage>. <pub-id pub-id-type="doi">10.1016/s1567-5769(03)00021-3</pub-id><pub-id pub-id-type="pmid">12860167</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="book"><collab>FAO/WHO</collab> (<year>2002</year>). <source/><italic>Guidelines for the Evaluation of Probiotics in Food: Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food</italic>.
<publisher-loc>Manila</publisher-loc>: <publisher-name>FAO/WHO</publisher-name>.</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Murga</surname><given-names>M. L.</given-names></name><name><surname>Sanz</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Safety assessment of <italic>Bacteroides uniformis</italic> CECT 7771 isolated from stools of healthy breast-fed infants.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0145503</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0145503</pub-id>
<pub-id pub-id-type="pmid">26784747</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>N.</given-names></name><name><surname>Gutierrez</surname><given-names>G.</given-names></name><name><surname>Lorenzo</surname><given-names>M.</given-names></name><name><surname>Garcia</surname><given-names>J. E.</given-names></name><name><surname>Piriz</surname><given-names>S.</given-names></name><name><surname>Quesada</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Genetic determinants for cfxA expression in <italic>Bacteroides</italic> strains isolated from human infections.</article-title>
<source/><italic>J. Antimicrob. Chemother.</italic>
<volume>62</volume>
<fpage>942</fpage>–<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn347</pub-id>
<pub-id pub-id-type="pmid">18775891</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Immuno-enhancement effects of <italic>Lycium ruthenicum</italic> Murr. polysaccharide on cyclophosphamide-induced immunosuppression in mice.</article-title>
<source/><italic>Int. J. Clin. Exp. Med.</italic>
<volume>8</volume>
<fpage>20631</fpage>–<lpage>20637</lpage>. <pub-id pub-id-type="pmid">26884983</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guindon</surname><given-names>S.</given-names></name><name><surname>Dufayard</surname><given-names>J. F.</given-names></name><name><surname>Hordijk</surname><given-names>W.</given-names></name><name><surname>Lefort</surname><given-names>V.</given-names></name><name><surname>Gascuel</surname><given-names>O.</given-names></name></person-group> (<year>2009</year>). <article-title>PhyML: fast and accurate phylogeny reconstruction by maximum likelihood.</article-title>
<source/><italic>Infect. Genet. Evol.</italic>
<volume>5</volume>
<fpage>384</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="pmid">14530136</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutacker</surname><given-names>M.</given-names></name><name><surname>Valsangiacomo</surname><given-names>C.</given-names></name><name><surname>Bernasconi</surname><given-names>M. V.</given-names></name><name><surname>Piffaretti</surname><given-names>J. C.</given-names></name></person-group> (<year>2002</year>). <article-title>recA and glnA sequences separate the <italic>Bacteroides fragilis</italic> population into two genetic divisions associated with the antibiotic resistance genotypes cepA and cfiA.</article-title>
<source/><italic>J. Med. Microbiol.</italic>
<volume>51</volume>
<fpage>123</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-51-2-123</pub-id>
<pub-id pub-id-type="pmid">11863263</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutacker</surname><given-names>M.</given-names></name><name><surname>Valsangiacomo</surname><given-names>C.</given-names></name><name><surname>Piffaretti</surname><given-names>J. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification of two genetic groups in <italic>Bacteroides fragilis</italic> by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes.</article-title>
<source/><italic>Microbiology</italic>
<volume>146</volume>
<fpage>1241</fpage>–<lpage>1254</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-146-5-1241</pub-id>
<pub-id pub-id-type="pmid">10832652</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamady</surname><given-names>Z. Z. R.</given-names></name><name><surname>Scott</surname><given-names>N.</given-names></name><name><surname>Farrar</surname><given-names>M. D.</given-names></name><name><surname>Lodge</surname><given-names>J. P. A.</given-names></name><name><surname>Holland</surname><given-names>K. T.</given-names></name><name><surname>Whitehead</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium <italic>Bacteroides ovatus</italic>.</article-title>
<source/><italic>Gut</italic>
<volume>59</volume>
<fpage>461</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2008.176131</pub-id>
<pub-id pub-id-type="pmid">19736360</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamady</surname><given-names>Z. Z. R.</given-names></name><name><surname>Scott</surname><given-names>N.</given-names></name><name><surname>Farrar</surname><given-names>M. D.</given-names></name><name><surname>Wadhwa</surname><given-names>M.</given-names></name><name><surname>Dilger</surname><given-names>P.</given-names></name><name><surname>Whitehead</surname><given-names>T. R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-beta 1 under the control of dietary xylan.</article-title>
<source/><italic>Inflamm. Bowel Dis.</italic>
<volume>17</volume>
<fpage>1925</fpage>–<lpage>1935</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21565</pub-id>
<pub-id pub-id-type="pmid">21830271</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsh</surname><given-names>M.</given-names></name><name><surname>Carmel</surname><given-names>J.</given-names></name><name><surname>Kaplan</surname><given-names>V.</given-names></name><name><surname>Livne</surname><given-names>E.</given-names></name><name><surname>Krausz</surname><given-names>M. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis.</article-title>
<source/><italic>Int. J. Exp. Pathol.</italic>
<volume>85</volume>
<fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1111/j.0959-9673.2004.00385.x</pub-id>
<pub-id pub-id-type="pmid">15255968</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houry</surname><given-names>A.</given-names></name><name><surname>Briandet</surname><given-names>R.</given-names></name><name><surname>Aymerich</surname><given-names>S.</given-names></name><name><surname>Gohar</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Involvement of motility and flagella in <italic>Bacillus cereus</italic> biofilm formation.</article-title>
<source/><italic>Microbiology</italic>
<volume>156</volume>
<fpage>1009</fpage>–<lpage>1018</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.034827-0</pub-id>
<pub-id pub-id-type="pmid">20035003</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>E. Y.</given-names></name><name><surname>McBride</surname><given-names>S. W.</given-names></name><name><surname>Hsien</surname><given-names>S.</given-names></name><name><surname>Sharon</surname><given-names>G.</given-names></name><name><surname>Hyde</surname><given-names>E. R.</given-names></name><name><surname>McCue</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders.</article-title>
<source/><italic>Cell</italic>
<volume>155</volume>
<fpage>1451</fpage>–<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id>
<pub-id pub-id-type="pmid">24315484</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>A 90-day oral toxicity study on a new strain of <italic>Lactobacillus paracasei</italic> in rats.</article-title>
<source/><italic>Food Chem. Toxicol.</italic>
<volume>49</volume>
<fpage>1148</fpage>–<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2011.02.006</pub-id>
<pub-id pub-id-type="pmid">21335050</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K.</given-names></name><name><surname>Standley</surname><given-names>D. M.</given-names></name></person-group> (<year>2013</year>). <article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability.</article-title>
<source/><italic>Mol. Biol. Evol.</italic>
<volume>4</volume>
<fpage>772</fpage>–<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/mst010</pub-id>
<pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>A. D.</given-names></name><name><surname>Wardenburg</surname><given-names>J. B.</given-names></name><name><surname>Gardner</surname><given-names>D. J.</given-names></name><name><surname>Long</surname><given-names>D.</given-names></name><name><surname>Whitney</surname><given-names>A. R.</given-names></name><name><surname>Braughton</surname><given-names>K. R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.</article-title>
<source/><italic>J. Infect. Dis.</italic>
<volume>202</volume>
<fpage>1050</fpage>–<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1086/656043</pub-id>
<pub-id pub-id-type="pmid">20726702</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Krieg</surname><given-names>N. R.</given-names></name><name><surname>Ludwig</surname><given-names>W.</given-names></name><name><surname>Euzeby</surname><given-names>J.</given-names></name><name><surname>Whitman</surname><given-names>W. B.</given-names></name></person-group> (<year>2001</year>). <source/><italic>Bergey’s Manual of Systematic Bacteriology</italic>
<edition>2nd Edn</edition>
<volume>Vol. 1</volume>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>M. C.</given-names></name><name><surname>Alteri</surname><given-names>C. J.</given-names></name><name><surname>Smith</surname><given-names>S. N.</given-names></name><name><surname>Mobley</surname><given-names>H. L. T.</given-names></name></person-group> (<year>2007</year>). <article-title>Expression of flagella is coincident with uropathogenic <italic>Escherichia coli</italic> ascension to the upper urinary tract.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>16669</fpage>–<lpage>16674</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0607898104</pub-id>
<pub-id pub-id-type="pmid">17925449</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R. Q.</given-names></name><name><surname>Li</surname><given-names>Y. R.</given-names></name><name><surname>Kristiansen</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>SOAP: short oligonucleotide alignment program.</article-title>
<source/><italic>Bioinformatics</italic>
<volume>24</volume>
<fpage>713</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btn025</pub-id>
<pub-id pub-id-type="pmid">18227114</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R. Q.</given-names></name><name><surname>Zhu</surname><given-names>H. M.</given-names></name><name><surname>Ruan</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>W. B.</given-names></name><name><surname>Fang</surname><given-names>X. D.</given-names></name><name><surname>Shi</surname><given-names>Z. B.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>De novo assembly of human genomes with massively parallel short read sequencing.</article-title>
<source/><italic>Genome Res.</italic>
<volume>20</volume>
<fpage>265</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1101/gr.097261.109</pub-id>
<pub-id pub-id-type="pmid">20019144</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B. X.</given-names></name><name><surname>Leong</surname><given-names>H. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Computational methods for predicting genomic islands in microbial genomes.</article-title>
<source/><italic>Comp. Struct. Biotechnol. J.</italic>
<volume>14</volume>
<fpage>200</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2016.05.001</pub-id>
<pub-id pub-id-type="pmid">27293536</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name><name><surname>Round</surname><given-names>J. L.</given-names></name><name><surname>Kasper</surname><given-names>D. L.</given-names></name></person-group> (<year>2008</year>). <article-title>A microbial symbiosis factor prevents intestinal inflammatory disease.</article-title>
<source/><italic>Nature</italic>
<volume>453</volume>
<fpage>620</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/nature07008</pub-id>
<pub-id pub-id-type="pmid">18509436</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname><given-names>A. G.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>Nizam</surname><given-names>F.</given-names></name><name><surname>Yan</surname><given-names>A.</given-names></name><name><surname>Azad</surname><given-names>M. A.</given-names></name><name><surname>Baylay</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The comprehensive antibiotic resistance database.</article-title>
<source/><italic>Antimicrob. Agents Chemother.</italic>
<volume>57</volume>
<fpage>3348</fpage>–<lpage>3357</lpage>. <pub-id pub-id-type="doi">10.1128/aac.00419-13</pub-id>
<pub-id pub-id-type="pmid">23650175</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto-Shinohara</surname><given-names>Y.</given-names></name><name><surname>Imaizumi</surname><given-names>T.</given-names></name><name><surname>Sukenobe</surname><given-names>J.</given-names></name><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Kawamura</surname><given-names>S.</given-names></name><name><surname>Komatsu</surname><given-names>Y.</given-names></name></person-group> (<year>2000</year>). <article-title>Survival rate of microbes after freeze-drying and long-term storage.</article-title>
<source/><italic>Cryobiology</italic>
<volume>41</volume>
<fpage>251</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1006/cryo.2000.2282</pub-id>
<pub-id pub-id-type="pmid">11161557</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>A. P.</given-names></name><name><surname>Texeira</surname><given-names>T. F.</given-names></name><name><surname>Ferreira</surname><given-names>A. B.</given-names></name><name><surname>Peluzio Mdo</surname><given-names>C.</given-names></name><name><surname>Alfenas Rde</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.</article-title>
<source/><italic>Br. J. Nutr.</italic>
<volume>108</volume>
<fpage>801</fpage>–<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1017/s0007114512001213</pub-id>
<pub-id pub-id-type="pmid">22717075</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neville</surname><given-names>B. A.</given-names></name><name><surname>Forde</surname><given-names>B. M.</given-names></name><name><surname>Claesson</surname><given-names>M. J.</given-names></name><name><surname>Darby</surname><given-names>T.</given-names></name><name><surname>Coghlan</surname><given-names>A.</given-names></name><name><surname>Nally</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Characterization of pro-inflammatory flagellin proteins produced by <italic>Lactobacillus ruminis</italic> and related motile Lactobacilli.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>40592</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0040592</pub-id>
<pub-id pub-id-type="pmid">22808200</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Toole</surname><given-names>P. W.</given-names></name><name><surname>Marchesi</surname><given-names>J. R.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Next-generation probiotics: the spectrum from probiotics to live biotherapeutics.</article-title>
<source/><italic>Nat. Microbiol.</italic>
<volume>2</volume>:<issue>17057</issue>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.57</pub-id>
<pub-id pub-id-type="pmid">28440276</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>K. P.</given-names></name><name><surname>Smith</surname><given-names>C. J.</given-names></name><name><surname>Gough</surname><given-names>A. M.</given-names></name><name><surname>Rocha</surname><given-names>E. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Characterization of <italic>Bacteroides fragilis</italic> hemolysins and regulation and synergistic interactions of HlyA and HlyB.</article-title>
<source/><italic>Infect. Immun.</italic>
<volume>74</volume>
<fpage>2304</fpage>–<lpage>2316</lpage>. <pub-id pub-id-type="doi">10.1128/iai.74.4.2304-2316.2006</pub-id>
<pub-id pub-id-type="pmid">16552061</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>M. B.</given-names></name><name><surname>Bennett</surname><given-names>T. K.</given-names></name><name><surname>Payne</surname><given-names>C. M.</given-names></name><name><surname>Smith</surname><given-names>C. J.</given-names></name></person-group> (<year>1994</year>). <article-title>Insertional activation of cepA leads to high-level beta-lactamase expression in <italic>Bacteroides fragilis</italic> clinical isolates.</article-title>
<source/><italic>J. Bacteriol.</italic>
<volume>176</volume>
<fpage>4376</fpage>–<lpage>4384</lpage>. <pub-id pub-id-type="doi">10.1128/jb.176.14.4376-4384.1994</pub-id>
<pub-id pub-id-type="pmid">7517394</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salva</surname><given-names>S.</given-names></name><name><surname>Marranzino</surname><given-names>G.</given-names></name><name><surname>Villena</surname><given-names>J.</given-names></name><name><surname>Aguero</surname><given-names>G.</given-names></name><name><surname>Alvarez</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Probiotic <italic>Lactobacillus</italic> strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice.</article-title>
<source/><italic>Int. Immunopharmacol.</italic>
<volume>22</volume>
<fpage>209</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2014.06.017</pub-id>
<pub-id pub-id-type="pmid">24975836</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvetti</surname><given-names>E.</given-names></name><name><surname>Orru</surname><given-names>L.</given-names></name><name><surname>Capozzi</surname><given-names>V.</given-names></name><name><surname>Martina</surname><given-names>A.</given-names></name><name><surname>Lamontanara</surname><given-names>A.</given-names></name><name><surname>Keller</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Integrate genome-based assessment of safety for probiotic strains: <italic>Bacillus coagulans</italic> GBI-30, 6086 as a case study.</article-title>
<source/><italic>Appl. Microbiol. Biotechnol.</italic>
<volume>100</volume>
<fpage>4595</fpage>–<lpage>4605</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-016-7416-9</pub-id>
<pub-id pub-id-type="pmid">26952108</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>C. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Enterotoxigenic <italic>Bacteroides fragilis</italic>: a rogue among symbiotes.</article-title>
<source/><italic>Clin. Microbiol. Rev.</italic>
<volume>22</volume>
<fpage>349</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00053-08</pub-id>
<pub-id pub-id-type="pmid">19366918</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>C.</given-names></name><name><surname>Prakash</surname><given-names>C.</given-names></name><name><surname>Tiwari</surname><given-names>K. N.</given-names></name><name><surname>Mishra</surname><given-names>S. K.</given-names></name><name><surname>Kumar</surname><given-names>V.</given-names></name></person-group> (<year>2018</year>). <article-title><italic>Premna integrifolia</italic> ameliorates cyclophosphamide-induced hepatotoxicity by modulation of oxidative stress and apoptosis.</article-title>
<source/><italic>Biomed. Pharmacother.</italic>
<volume>107</volume>
<fpage>634</fpage>–<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.08.039</pub-id>
<pub-id pub-id-type="pmid">30118879</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>H. Z.</given-names></name><name><surname>Zhao</surname><given-names>J. X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Zhai</surname><given-names>Q. X.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group> (<year>2018</year>). <article-title>Isolation of low-abundant Bacteroidales in the human intestine and the analysis of their differential utilization based on plant-derived polysaccharides.</article-title>
<source/><italic>Front. Microbiol.</italic>
<volume>9</volume>:<issue>1319</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.01319</pub-id>
<pub-id pub-id-type="pmid">29971058</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulsemer</surname><given-names>P.</given-names></name><name><surname>Henderson</surname><given-names>G.</given-names></name><name><surname>Toutounian</surname><given-names>K.</given-names></name><name><surname>Loffler</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>J.</given-names></name><name><surname>Karsten</surname><given-names>U.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium <italic>Bacteroides ovatus</italic> D-6.</article-title>
<source/><italic>Cancer Immunol. Immunother.</italic>
<volume>62</volume>
<fpage>875</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1007/s00262-013-1394-x</pub-id>
<pub-id pub-id-type="pmid">23381581</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulsemer</surname><given-names>P.</given-names></name><name><surname>Toutounian</surname><given-names>K.</given-names></name><name><surname>Schmidt</surname><given-names>J.</given-names></name><name><surname>Karsten</surname><given-names>U.</given-names></name><name><surname>Goletz</surname><given-names>S.</given-names></name></person-group> (<year>2012a</year>). <article-title>Preliminary safety evaluation of a new <italic>Bacteroides xylanisolvens</italic> isolate.</article-title>
<source/><italic>Appl. Environ. Microbiol.</italic>
<volume>78</volume>
<fpage>528</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1128/aem.06641-11</pub-id>
<pub-id pub-id-type="pmid">22101046</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulsemer</surname><given-names>P.</given-names></name><name><surname>Toutounian</surname><given-names>K.</given-names></name><name><surname>Schmidt</surname><given-names>J.</given-names></name><name><surname>Leuschner</surname><given-names>J.</given-names></name><name><surname>Karsten</surname><given-names>U.</given-names></name><name><surname>Goletz</surname><given-names>S.</given-names></name></person-group> (<year>2012b</year>). <article-title>Safety assessment of the commensal strain <italic>Bacteroides xylanisolvens</italic> DSM 23964.</article-title>
<source/><italic>Regul. Toxicol. Pharmacol.</italic>
<volume>62</volume>
<fpage>336</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/j.yrtph.2011.10.014</pub-id>
<pub-id pub-id-type="pmid">22085591</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>H. M.</given-names></name><name><surname>Li</surname><given-names>Z. C.</given-names></name><name><surname>Tan</surname><given-names>Y. F.</given-names></name><name><surname>Han</surname><given-names>Y. P.</given-names></name><name><surname>Wang</surname><given-names>X. Y.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Safety evaluation of a novel strain of <italic>Bacteroides fragilis</italic>.</article-title>
<source/><italic>Front. Microbiol.</italic>
<volume>8</volume>:<issue>435</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.00435</pub-id>
<pub-id pub-id-type="pmid">28367145</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassenaar</surname><given-names>T. M.</given-names></name><name><surname>Zschüttig</surname><given-names>A.</given-names></name><name><surname>Beimfohr</surname><given-names>C.</given-names></name><name><surname>Geske</surname><given-names>T.</given-names></name><name><surname>Auerbach</surname><given-names>C.</given-names></name><name><surname>Cook</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Virulence genes in a probiotic <italic>E. coli</italic> product with a recorded long history of safe use.</article-title>
<source/><italic>Eur. J. Microbiol. Immunol.</italic>
<volume>5</volume>
<fpage>81</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1556/EUJMI-D-14-00039</pub-id>
<pub-id pub-id-type="pmid">25883796</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>B.</given-names></name><name><surname>Dalwadi</surname><given-names>H.</given-names></name><name><surname>Gordon</surname><given-names>L. K.</given-names></name><name><surname>Landers</surname><given-names>C.</given-names></name><name><surname>Bruckner</surname><given-names>D.</given-names></name><name><surname>Targan</surname><given-names>S. R.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Molecular cloning of a <italic>Bacteroides</italic> caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.</article-title>
<source/><italic>Infect. Immun.</italic>
<volume>69</volume>
<fpage>6044</fpage>–<lpage>6054</lpage>. <pub-id pub-id-type="doi">10.1128/iai.69.10.6044-6054.2001</pub-id>
<pub-id pub-id-type="pmid">11553542</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilke</surname><given-names>G. A.</given-names></name><name><surname>Wardenburg</surname><given-names>J. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>13473</fpage>–<lpage>13478</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1001815107</pub-id>
<pub-id pub-id-type="pmid">20624979</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakabe</surname><given-names>T.</given-names></name><name><surname>Moore</surname><given-names>E. L.</given-names></name><name><surname>Yokota</surname><given-names>S.</given-names></name><name><surname>Sui</surname><given-names>H.</given-names></name><name><surname>Nobuta</surname><given-names>Y.</given-names></name><name><surname>Fukao</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Safety assessment of <italic>Lactobacillus brevis</italic> KB290 as a probiotic strain.</article-title>
<source/><italic>Food Chem. Toxicol.</italic>
<volume>47</volume>
<fpage>2450</fpage>–<lpage>2453</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2009.07.001</pub-id>
<pub-id pub-id-type="pmid">19583990</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>S.</given-names></name><name><surname>Gwon</surname><given-names>S. Y.</given-names></name><name><surname>Hwang</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>N. H.</given-names></name><name><surname>Jung</surname><given-names>B. D.</given-names></name><name><surname>Rhee</surname><given-names>K. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Enterotoxigenic <italic>Bacteroides fragilis</italic> causes lethal colitis in Mongolian gerbil.</article-title>
<source/><italic>Anaerobe</italic>
<volume>21</volume>
<fpage>64</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.03.008</pub-id>
<pub-id pub-id-type="pmid">23538057</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>